0
2020
Autoinjectors Market

Autoinjectors Market

by Type (Disposable Autoinjectors and Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), and End user (Homecare Settings and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2020-2027
Update Available On-Demand

Report Code: A01142
Pages: 225
Sep 2020 | 10886 Views
Author(s) : Ankita S , Onkar S
Tables: 119
Charts: 56
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Autoinjectors Market

Request Now !

The global autoinjectors market was valued at $ 1,509.0 million in 2019, and is expected to reach $ 5,732.6 million by 2027, with a CAGR of 18.1% during the forecast period. 

An autoinjector is a syringe with a spring-charged needle having a pre-charged dosage of drugs. The system triggers and administers a measured dosage of a drug, when pressed into the body with a sliding motion. Autoinjectors are widely used for epinephrine self-administration (to prevent anaphylaxis); by migraine sufferers (for immediate pain relief); or for medical and emergency treatments. Auto-injectors provide multiple benefits such as decreasing needle-related phobia disorder, decreasing risks of needle stuck accidents, ensuring dosage quality continuity, and helping increase effectiveness. 

Autoinjectors-Market-2020-2027

The autoinjector market is expected to register a substantial growth in the future, owing to rise in anaphylaxis cases. In addition, rise in R&D efforts by companies to develop simple, cost effective, and new technology based autoinjectors for treatment of chronic diseases such as rheumatoid arthritis and multiple sclerosis is expected to boost the market growth during the forecast period. 

However, availability of alternative treatment options is anticipated to hamper the market growth during the forecast period. On the contrary, a fundamental shift from biologics to biosimilars, which are delivered through autoinjectors are anticipated to provide lower cost options to patients opting for prolonged treatment. These factors are expected to provide remunerative opportunities for the market players.

The autoinjectors market is segmented on the basis of type, application, end user, and region. By type, it is categorized into disposable and reusable autoinjectors. On the basis of application, it is divided into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and others. By end user, it is categorized into home care settings and hospitals & clinics. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Depending on type, the market is categorized into disposable and reusable autoinjectors. The disposable autoinjectors segment dominated the global market in 2019, and is anticipated to continue this trend during the forecast period. The key factors such as rise in prevalence of anaphylaxis and rheumatoid arthritis and further increasing patient preference for autoinjectors drives the growth of this treatment segment.The use of autoinjectors has benefits such as rapid action and simplified administration

On the basis of application, the market is categorized into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and others. The anaphylaxis segment held a dominant position in the market, accounting for about 38.5% share of the global autoinjectors market in 2019. 

By end user, the market is categorized into home care settings and hospitals & clinics. The home care settings segment held a dominant portion in the market, accounting for about 62.8% share of the global autoinjectors market in 2019. 

North America accounted for the largest share in the global autoinjectors market. Asia-Pacific is expected to witness highest growth rate throughout the forecast period. Rise in cases of anaphylaxis; rheumatoid arthritis; and other diseases such as anemia and migraine; and further increase in technological advancements by companies are anticipated to drive the overall market growth. 

Autoinjectors Market
By Type

Your browser does not support the canvas element.

Disposable autoinjectors is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Global Autoinjectors Market Segmentation

The autoinjectors market is segmented on the basis oftype, application, end user, and region. By type,it is categorized into disposable and reusable autoinjectors. On the basis of application, it is divided into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and others. By end user, it is categorized into home care settings and hospitals & clinics. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment review

Depending on type, the market is categorized into disposable and reusable autoinjectors. The disposable autoinjectors segment dominated the global market in 2019, and is anticipated to continue this trend during the forecast period. The key factors such as rise in prevalence of anaphylaxis and rheumatoid arthritis and further increase in patient preference for autoinjectors drive thegrowth of this treatment segment.

On the basis of application, the market is categorized into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and others. The anaphylaxis segment held a dominant position in the market, accounting for about 38.5% share of the global autoinjectors market in 2019. 

Autoinjectors Market
By Application

Your browser does not support the canvas element.

Anaphylaxis segment holds a dominant position in 2019 and rheumatoid arthritis segment will lead over the forecast period.

Get more information on this report : Request Sample Pages

By end user, the market is categorized into home care settings and hospitals & clinics. The home care settings segment held a dominant portion in the market, accounting for about 62.8% share of the global autoinjectors market in 2019.

The major companies profiled in this report includeAmgen, Antares Pharma, Becton Dickinson and Company, Eli Lilly and Company, Johnson and Johnson, Mylan N.V., Novartis AG, SHL Medical, Teva Pharmaceutical Industries Ltd, and Ypsomed AG. Other players in the autoinjectors market (not profiled in the report) include Biogen Idec, Owen Mumford, Consort Medical, Abbvie, and Gerresheimer.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global autoinjectors market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers autoinjectors market analysis from 2020to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities. 
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global autoinjectors market growth.

Key Market Segments

By Type 

  • Disposable autoinjectors 
  • Reusable autoinjectors 

By Application 

  • Rheumatoid Arthritis
  • Anaphylaxis
  • Multiple Sclerosis
  • Others

By End user 

  • Home care settings
  • Hospitals & Clinics 

By Region 

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK 
    • Germany 
    • France 
    • Italy
    • Spain 
    • Rest of Europe
  • Asia-Pacific
    • Japan 
    • China
    • Australia 
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Loading Table Of Content...


 
 

An autoinjector is a medical device designed to deliver doses of a particular drug. They are deigned to overcome the phobia of needles and to reduce needle prick pain in patients, especially for those who are undergoing a treatment with frequent injections. Autoinjectors are used for treatment of multiple sclerosis, rheumatoid arthritis, and other diseases such as anemia, migraine, seizures, and few cardiovascular diseases.

The treatments with help of autoinjectors for chronic diseases is anticipated to witness a significant growth. This is attributed to the rise in number of chronic diseases cases, technological advancements by market players and increase in patient preference to opt for self-injections systems. Furthermore, increase in research and development activities by key market players and availability of low cost biosimilars in combination with autoinjectors for treatment of chronic diseases are expected to drive the market growth during the forecast period. Moreover, rise in adoption of autoinjectors by patients for treatment of various diseases is expected to provide lucrative opportunities for the market. 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total value of Autoinjectors market was $ 1,509.0 million in 2019.

A. The forecast period in the report is from 2020-2027.

A. The market value of Autoinjectors market in 2020 was $1,790.9 million.

A. The base year calculated is 2019 in the report.

A. As per the key industry leaders, rise in incidence of chronic diseases cases , increasing R&D initiatives to develop novel technologies and paradigm shift from biologics to biosimilars will drive the market

A. Rise in R&D efforts by the key players to develop novel therapies in the market is expected to drive the market growth during the forecast period.

A. The growth % of the Autoinjectors market is 18.1%.

A. Disposable autoinjectors segment holds the maximum market share.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Autoinjectors Market

Start reading instantly.
This Report and over 19,320+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Sep 2021 - Sep 2022)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2021 - Sep 2022)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2021 - Sep 2022)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2021 - Sep 2022)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2021 - Sep 2022)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers